Half-year report · HY
4572.TEDINET S100YV1G
Period2026-01-01 → 2026-06-30
Filed2026-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥401m | 2026-01-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥579m | 2025-01-01 → 2025-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥251m | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Operating income | −¥954m | 2026-01-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | −¥1.0bn | 2026-01-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥2.1bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥1.0bn | 2026-01-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥1.0bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.2bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥1.0bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥1.8bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥1.2bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥1.6bn | at 2025-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.2bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥920m | at 2025-12-31 | Cons. | Liabilities |
| Net assets / equity | −¥408m | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥309m | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.4bn | at 2025-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥517m | at 2025-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥517m | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2024-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥915m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥2.2bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥995m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥11m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥25m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥16m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.5bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥605m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥14m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-53.13 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-113.62 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-55.29 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | -23.9% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.1% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.1% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 8
| Segment | Item | Period | Value |
|---|---|---|---|
| Drug Discovery Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | −¥1.0bn |
| Drug Discovery Support Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥401m |
| Drug Discovery Support Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥401m |
| Drug Discovery Support Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥67m |
| Drug Discovery Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥1.0bn |
| Drug Discovery Support Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥251m |
| Drug Discovery Support Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥251m |
| Drug Discovery Support Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥51m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 442
| Item | Context | Value | Unit |
|---|---|---|---|
| Valuation difference on available for sale securities | Prior1YearInstant | -2862000 | JPY |
| Valuation difference on available for sale securities | InterimInstant | 229000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 81424000 | JPY |
| Foreign currency translation adjustment | InterimInstant | 91989000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 78562000 | JPY |
| Valuation and translation adjustments | InterimInstant | 92219000 | JPY |
| Subscription rights to shares | Prior1YearInstant | － | JPY |
| Subscription rights to shares | InterimInstant | 14840000 | JPY |
| Net assets | Prior1YearInstant | 309217000 | JPY |
| Net assets | InterimInstant | -407840000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 1229648000 | JPY |
| Liabilities and net assets | InterimInstant | 1765502000 | JPY |
| Net sales | Prior1InterimDuration | 251097000 | JPY |
| Net sales | InterimDuration | 401154000 | JPY |
| Cost of sales | Prior1InterimDuration | 77358000 | JPY |
| Cost of sales | InterimDuration | 108648000 | JPY |
| Gross profit | Prior1InterimDuration | 173738000 | JPY |
| Gross profit | InterimDuration | 292505000 | JPY |
| Selling general and administrative expenses | Prior1InterimDuration | 1226580000 | JPY |
| Selling general and administrative expenses | InterimDuration | 1246617000 | JPY |
| Operating income | Prior1InterimDuration | -1052841000 | JPY |
| Operating income | InterimDuration | -954112000 | JPY |
| Interest income noi | Prior1InterimDuration | 2999000 | JPY |
| Interest income noi | InterimDuration | 819000 | JPY |
| Dividends income noi | Prior1InterimDuration | 1528000 | JPY |
| Dividends income noi | InterimDuration | 1300000 | JPY |
| Other noi | Prior1InterimDuration | 98000 | JPY |
| Other noi | InterimDuration | 2243000 | JPY |
| Non operating income | Prior1InterimDuration | 4626000 | JPY |
| Non operating income | InterimDuration | 4362000 | JPY |
| Interest expenses noe | Prior1InterimDuration | 895000 | JPY |
| Interest expenses noe | InterimDuration | 34219000 | JPY |
| Guarantee commission noe | Prior1InterimDuration | 198000 | JPY |
| Guarantee commission noe | InterimDuration | 165000 | JPY |
| Stock issuance cost noe | Prior1InterimDuration | 91000 | JPY |
| Stock issuance cost noe | InterimDuration | 936000 | JPY |
| Share acquisition rights issuance costs noe | Prior1InterimDuration | － | JPY |
| Share acquisition rights issuance costs noe | InterimDuration | 11613000 | JPY |
| Foreign exchange losses noe | Prior1InterimDuration | 5624000 | JPY |
| Foreign exchange losses noe | InterimDuration | 9113000 | JPY |
| Non operating expenses | Prior1InterimDuration | 6809000 | JPY |
| Non operating expenses | InterimDuration | 56048000 | JPY |
| Ordinary income | Prior1InterimDuration | -1055024000 | JPY |
| Ordinary income | InterimDuration | -1005798000 | JPY |
| Impairment loss el | Prior1InterimDuration | 315000 | JPY |
| Impairment loss el | InterimDuration | 12350000 | JPY |
| Loss on bond retirement noe | Prior1InterimDuration | － | JPY |
| Loss on bond retirement noe | InterimDuration | 20138000 | JPY |
| Extraordinary loss | Prior1InterimDuration | 315000 | JPY |
| Extraordinary loss | InterimDuration | 32489000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |